Clinical Risk & Patient Injury: Insurance Implications for Medical Device Manufacturers (UK)

Introduction: why clinical risk matters to manufacturers

Clinical risk is usually discussed in hospitals and clinics, but manufacturers sit right in the middle of it. If a device contributes to a patient injury—whether through a design issue, a manufacturing defect, unclear instructions, or a software failure—the financial and legal impact can land on the manufacturer quickly.

In the UK, patient injury can trigger product liability claims, regulatory scrutiny, recalls, contract disputes, and reputational damage. The right insurance programme won’t prevent an incident, but it can protect your balance sheet and keep the business trading while you investigate, remediate, and defend claims.

What counts as “patient injury” in a device context?

Patient injury isn’t only catastrophic, headline-grabbing events. It can include:

• Minor burns, lacerations, pressure injuries, or allergic reactions
• Infection linked to a device, packaging, or sterilisation failure
• Misdiagnosis or delayed diagnosis due to device performance or software output
• Over- or under-dosing from infusion, monitoring, or delivery systems
• Device migration, breakage, or mechanical failure
• Harm caused by user error where the instructions, training, or interface design are questioned
• Data integrity issues that lead to clinical decisions based on wrong information

From an insurance standpoint, the key question is often: did the product (including its labelling, instructions, software, and updates) contribute to bodily injury?

Where clinical risk comes from: common manufacturer exposures

Even strong quality systems can’t eliminate risk. The most common sources of clinical risk for manufacturers include:

1) Design and engineering risk

• Human factors issues (confusing UI, alarms, workflows)
• Failure to anticipate foreseeable misuse
• Design tolerances that don’t hold in real-world clinical settings
• Software logic errors, edge cases, or interoperability failures

2) Manufacturing and quality risk

• Contamination or sterilisation failures
• Batch variation, component substitution, or supplier quality drift
• Inadequate in-process testing or release criteria
• Packaging failures leading to loss of sterility

3) Labelling, IFU and training risk

• Ambiguous instructions for use (IFU)
• Missing contraindications, warnings, or limitations
• Poor training materials or inconsistent field training

4) Post-market and change-control risk

• Delayed response to complaints or adverse events
• Inadequate CAPA (corrective and preventive actions)
• Software updates introducing new hazards
• Incomplete traceability for affected lots/serials

5) Clinical evaluation and evidence risk

• Overstated performance claims
• Weak clinical evaluation or insufficient real-world evidence
• Misalignment between intended use and actual use in the field

Liability basics: who can be pursued after an injury?

In a patient injury scenario, claims can involve multiple parties:

• Manufacturer (including legal manufacturer and any UK Responsible Person where relevant)
• Importer or distributor
• Contract manufacturer
• Component suppliers n- Hospital or clinician (clinical negligence)
• Service/maintenance provider
• Software or connectivity partners

Claimants and claimant solicitors often pursue the party with the clearest route to compensation and the strongest insurance. That’s one reason manufacturers need clarity on contractual indemnities and who carries what cover.

The legal and regulatory backdrop (high level)

You don’t need to be a lawyer to understand the practical implications:

• Product liability: claims alleging the product was defective and caused injury.
• Negligence: claims alleging a failure to take reasonable care (design, warnings, testing, post-market action).
• Contractual liability: claims between businesses (e.g., distributor alleges you breached warranties).
• Regulatory action: investigations, field safety corrective actions (FSCAs), and potential suspension of supply.

Insurance won’t “fix” regulatory breaches, but it can fund defence costs and certain incident-related costs depending on policy wording.

How insurance typically responds: the core covers

A manufacturer’s insurance programme usually needs to address three overlapping realities: injury claims, operational disruption, and the cost of managing an incident.

1) Product Liability (often within Public & Products Liability)

This is the backbone for patient injury exposure. It is designed to respond to third-party claims alleging your product caused bodily injury or property damage.

What it can help with:

• Legal defence costs (often the biggest immediate cost)
• Compensation and claimant costs (where you are legally liable)
• Some associated expenses, subject to policy terms

Key points to check:

• Territory and jurisdiction: UK-only vs worldwide, and whether USA/Canada are included (often restricted or priced separately)
• Definition of “product”: includes software, accessories, consumables, packaging, and updates
• Retroactive date / claims-made vs occurrence: especially relevant for long-tail injury allegations
• Exclusions: known defects, deliberate non-compliance, contractual liability beyond common law

2) Clinical Trials Liability (if you run studies)

If you conduct clinical investigations, you may need specific clinical trials liability cover. This is often required by ethics committees, sponsors, or contracts.

It can help with:

• Injury claims arising from trial participation
• Legal defence and compensation, subject to protocol compliance

Watch-outs:

• Whether the policy covers the exact trial, sites, and territories
• Whether it includes non-negligent harm (some arrangements do, some don’t)
• How it interacts with sponsor agreements and indemnities

3) Professional Indemnity (PI) / Errors & Omissions (E&O)

For manufacturers, PI/E&O can be relevant where the allegation is about professional services, advice, or design work—particularly for:

• Software as a medical device (SaMD)
• Design and development services for third parties
• Consultancy, integration, configuration, or training services

PI/E&O is often triggered by financial loss claims, but some policies can be extended to include bodily injury in limited circumstances. Don’t assume it does—check.

4) Product Recall / Contaminated Products (specialist cover)

A recall can be financially brutal even without proven injury. Specialist recall cover may help with:

• Recall logistics, communications, and disposal
• Extra costs to replace or repair products
• Crisis management support

Important: many standard liability policies do not pay for the cost of recalling your own product unless there is a specific extension.

5) Cyber Insurance (for connected devices and data)

If device connectivity, remote monitoring, or cloud platforms are involved, cyber cover can become part of the patient injury story.

Cyber policies can help with:

• Incident response and forensic costs
• Notification and regulatory engagement (where applicable)
• Business interruption from network outages

Cyber is not a substitute for product liability. But where a cyber event leads to patient harm allegations, you want clarity on how the cyber and liability policies interact.

The “grey areas” that cause claim disputes

Insurance claims in this space often become complicated because the incident doesn’t fit neatly into one box. Common grey areas include:

• Software updates: is harm caused by a “product defect” or a “professional service error”?
• Training and implementation: is it product liability, or PI?
• Known issues: when did you first become aware, and what did you do next?
• Contractual indemnities: you may have agreed to take on liabilities beyond what your policy covers.
• US exposure: even a small number of US sales can change the risk profile.

The solution is usually a mix of correct policy structure and clean documentation of your risk controls.

What insurers and underwriters will ask (and why)

When you approach insurers for medical device risk, expect questions such as:

• What is the device type, intended use, and patient contact level?
• Where is it sold (UK/EU/US/ROW) and what is the revenue split?
• What standards and quality systems do you operate (e.g., ISO 13485)?
• What is your complaint handling and vigilance process?
• Do you have post-market surveillance data and trend reporting?
• Any previous incidents, recalls, or regulator engagement?
• Who are your critical suppliers and how do you control them?
• How do you manage software development, validation, and updates?

These questions aren’t just box-ticking. Underwriters are trying to understand frequency (how often incidents might occur) and severity (how bad a worst-case claim could be).

Practical risk controls that also help your insurance position

Insurers like evidence of control. The same controls that reduce patient harm can also reduce premiums and improve terms.

• Strong design controls and documented risk management
• Human factors engineering and usability testing
• Supplier audits and incoming inspection for critical components
• Clear traceability (lot/serial) and robust UDI processes
• Post-market surveillance with defined escalation triggers
• Fast, documented CAPA and field action decision-making
• Clear IFU, labelling, and training materials with version control
• Cyber security by design for connected products

If you can show these are real, lived processes (not just policies), you’re in a better position when negotiating cover.

Building the right insurance programme: a simple checklist

When you’re reviewing your cover, aim to confirm:

1. Product liability limit fits your worst-case scenario and contractual requirements.
2. Worldwide territory/jurisdiction matches where products are used, not just where you’re based.
3. Clinical trials cover is in place for any investigations and aligns with protocols.
4. Recall cover is considered if a recall would threaten cashflow.
5. Cyber cover supports connected device risk and incident response.
6. Contract review is part of your process (indemnities, hold harmless, limitation of liability).
7. Claims notification process is clear internally—who tells the broker/insurer, and when.

What to do after an incident (from an insurance perspective)

If a patient injury allegation arises, early steps matter:

• Preserve evidence: device, packaging, logs, and service records
• Document the timeline and who knew what, when
• Notify your broker/insurer early (late notification can cause coverage issues)
• Avoid admissions of liability before advice
• Align regulatory reporting and insurance reporting so facts are consistent
• Track costs separately (investigation, legal, recall, comms)

The goal is to protect patients first, then protect the business while the facts are established.

FAQs

Does product liability insurance cover patient injury claims?

Often, yes—if the policy includes products liability and the claim alleges your product caused bodily injury. Coverage depends on territory, exclusions, and whether the product and use fall within the declared business description.

Do we need clinical trials liability if we already have product liability?

Many manufacturers do, because trials create a specific exposure and are often contractually required. Product liability may not be designed to cover trial participation, especially across multiple sites or territories.

What about injuries caused by user error?

User error doesn’t automatically remove manufacturer exposure. Claims may argue the IFU, training, warnings, or interface design made the error foreseeable. Insurance response depends on the allegation and policy wording.

Are recalls covered under standard liability policies?

Usually not for your own recall costs. Liability policies may respond to third-party injury claims, but recall costs often require specialist product recall cover.

If our device is software-based, is this still product liability?

It can be. Many policies treat software as part of the product, but not all. If you provide services (configuration, advice, integration), PI/E&O may also be relevant.

Conclusion: insure the reality of your risk

Clinical risk and patient injury exposure isn’t just a compliance topic—it’s a business continuity issue. The most resilient manufacturers treat insurance as part of a wider risk system: strong design and quality controls, clear post-market processes, and a programme of cover that matches where and how the device is used.

If you want, share the device type, where it’s sold (UK/EU/US), and whether you run clinical investigations. I can tailor this into a sector-specific version with tighter keywords and a stronger conversion CTA for Insure24.